ARIAD PHARMACEUTICALS INC 4

4 · ARIAD PHARMACEUTICALS INC · Filed Mar 30, 2015

Form 4

Period: 2015-03-26

DirectorChairman & CEO

Transactions

Exercise/Conversion
Common Stock
2015-03-26$7.56/sh+26,454$199,992→ 1,347,108 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-26−12,544→ 0 total
Exercise: $7.56From: 2006-10-04Exp: 2015-10-04→ Common Stock (12,544 underlying)
Tax Payment
Common Stock
2015-03-26$8.17/sh−102,715$839,182→ 1,343,460 total
Exercise/Conversion
Common Stock
2015-03-26$7.56/sh+111,002$839,175→ 1,446,175 total
Tax Payment
Common Stock
2015-03-26$8.17/sh−24,479$199,993→ 1,322,629 total
Exercise/Conversion
Common Stock
2015-03-26$7.56/sh+12,544$94,833→ 1,335,173 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-26−26,454→ 0 total
Exercise: $7.56From: 2006-10-04Exp: 2015-10-04→ Common Stock (26,454 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-26−111,002→ 0 total
Exercise: $7.56From: 2006-10-04Exp: 2015-10-04→ Common Stock (111,002 underlying)

Holdings

Footnotes (3)

[F1]Shares were acquired upon the exercise of outstanding stock options at $7.56 per share.
[F2]Represents shares withheld to pay for the exercise cost related to the exercise of outstanding options and to satisy withholding tax requirements.
[F3]The reporting person is a managing member of this LLC.

Documents

1 file